Upregulation of CELSR1 expression promotes ovarian cancer cell proliferation, migration, and invasion

Ferlay J, Soerjomataram I, Dikshit R, Eser S, Mathers C, Rebelo M, Parkin DM, Forman D, Bray F. Cancer incidence and mortality worldwide: sources, methods and major patterns in GLOBOCAN 2012. Int J Cancer. 2015;136:E359-86. https://doi.org/10.1002/ijc.29210.

Article  CAS  PubMed  Google Scholar 

Torre LA, Trabert B, DeSantis CE, Miller KD, Samimi G, Runowicz CD, Gaudet MM, Jemal A, Siegel RL. Ovarian cancer statistics, 2018. CA Cancer J Clin. 2018;68:284–96. https://doi.org/10.3322/caac.21456.

Article  PubMed  PubMed Central  Google Scholar 

Nebgen DR, Lu KH, Bast RC Jr. Novel approaches to ovarian cancer screening. Curr Oncol Rep. 2019;21:75. https://doi.org/10.1007/s11912-019-0816-0.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Morice P, Gouy S, Leary A. Mucinous ovarian carcinoma. N Engl J Med. 2019;380:1256–66. https://doi.org/10.1056/NEJMra1813254.

Article  CAS  PubMed  Google Scholar 

Roett MA, Evans P. Ovarian cancer: an overview. Am Fam Physician. 2009;80:609–16.

PubMed  Google Scholar 

Peres LC, Cushing-Haugen KL, Köbel M, Harris HR, Berchuck A, Rossing MA, Schildkraut JM, Doherty JA. Invasive epithelial ovarian cancer survival by histotype and disease stage. J Natl Cancer Inst. 2019;111:60–8. https://doi.org/10.1093/jnci/djy071.

Article  PubMed  Google Scholar 

Matulonis UA, Sood AK, Fallowfield L, Howitt BE, Sehouli J, Karlan BY. Ovarian cancer. Nat Rev Dis Primers. 2016;2:16061. https://doi.org/10.1038/nrdp.2016.61.

Article  PubMed  PubMed Central  Google Scholar 

Rooth C. Ovarian cancer: risk factors, treatment and management. Br J Nurs. 2013;22:S23-30. https://doi.org/10.12968/bjon.2013.22.Sup17.S23.

Article  PubMed  Google Scholar 

Formstone CJ, Moxon C, Murdoch J, Little P, Mason I. Basal enrichment within neuroepithelia suggests novel function(s) for Celsr1 protein. Mol Cell Neurosci. 2010;44:210–22. https://doi.org/10.1016/j.mcn.2010.03.008.

Article  CAS  PubMed  Google Scholar 

Crompton LA, Du Roure C, Rodriguez TA. Early embryonic expression patterns of the mouse Flamingo and Prickle orthologues. Dev Dyn. 2007;236:3137–43. https://doi.org/10.1002/dvdy.21338.

Article  CAS  PubMed  Google Scholar 

Yates LL, Papakrivopoulou J, Long DA, Goggolidou P, Connolly JO, Woolf AS, Dean CH. The planar cell polarity gene Vangl2 is required for mammalian kidney-branching morphogenesis and glomerular maturation. Hum Mol Genet. 2010;19:4663–76. https://doi.org/10.1093/hmg/ddq397.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Zhan YH, Luo QC, Zhang XR, Xiao NA, Lu CX, Yue C, Wang N, Ma QL. CELSR1 Is a positive regulator of endothelial cell migration and angiogenesis. Biochemistry (Mosc). 2016;81:591–9. https://doi.org/10.1134/s0006297916060055.

Article  CAS  PubMed  Google Scholar 

Wang G, Li Y, Zhang D, Zhao S, Zhang Q, Luo C, Sun X, Zhang B. CELSR1 acts as an oncogene regulated by miR-199a-5p in glioma. Cancer Manag Res. 2020;12:8857–65. https://doi.org/10.2147/cmar.S258835.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Liao S, Desouki MM, Gaile DP, Shepherd L, Nowak NJ, Conroy J, Barry WT, Geradts J. Differential copy number aberrations in novel candidate genes associated with progression from in situ to invasive ductal carcinoma of the breast. Genes Chromosomes Cancer. 2012;51:1067–78. https://doi.org/10.1002/gcc.21991.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Kaucká M, Plevová K, Pavlová S, Janovská P, Mishra A, Verner J, Procházková J, Krejcí P, Kotasková J, Ovesná P, Tichy B, Brychtová Y, Doubek M, Kozubík A, Mayer J, Pospísilová S, Bryja V. The planar cell polarity pathway drives pathogenesis of chronic lymphocytic leukemia by the regulation of B-lymphocyte migration. Cancer Res. 2013;73:1491–501. https://doi.org/10.1158/0008-5472.Can-12-1752.

Article  PubMed  Google Scholar 

Young T, Mei F, Liu J, Bast RC Jr, Kurosky A, Cheng X. Proteomics analysis of H-RAS-mediated oncogenic transformation in a genetically defined human ovarian cancer model. Oncogene. 2005;24:6174–84. https://doi.org/10.1038/sj.onc.1208753.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Liu J, Yang G, Thompson-Lanza JA, Glassman A, Hayes K, Patterson A, Marquez RT, Auersperg N, Yu Y, Hahn WC, Mills GB, Bast RC Jr. A genetically defined model for human ovarian cancer. Cancer Res. 2004;64:1655–63. https://doi.org/10.1158/0008-5472.can-03-3380.

Article  CAS  PubMed  Google Scholar 

Hu MZ, Dai ZZ, Ji HY, Zheng AQ, Liang H, Shen MM, Liu JN, Tang KF, Zhu SJ, Wang KJ. Upregulation of FAM50A promotes cancer development. Med Oncol. 2023;40:217. https://doi.org/10.1007/s12032-023-02072-z.

Article  CAS  PubMed  Google Scholar 

Zhao Y, Tao F, Jiang J, Chen L, Du J, Cheng X, He Q, Zhong S, Chen W, Wu X, Ou R, Xu Y, Tang KF. Tryptophan 2, 3-dioxygenase promotes proliferation, migration and invasion of ovarian cancer cells. Mol Med Rep. 2021. https://doi.org/10.3892/mmr.2021.12084.

Article  PubMed  PubMed Central  Google Scholar 

Lin J, Zhang X, Meng F, Zeng F, Liu W, He X. PNMA5 accelerated cellular proliferation, invasion and migration in colorectal cancer. Am J Transl Res. 2022;14:2231–43.

CAS  PubMed  PubMed Central  Google Scholar 

Chen L, Yang J, Wang Y, Wu N, Li X, Li J, Huang Y, Cheng J. ATOH8 overexpression inhibits the tumor progression and monocyte chemotaxis in hepatocellular carcinoma. Int J Clin Exp Pathol. 2020;13:2534–43.

CAS  PubMed  PubMed Central  Google Scholar 

Liu J, Yu X, Yu H, Liu B, Zhang Z, Kong C, Li Z. Knockdown of MAPK14 inhibits the proliferation and migration of clear cell renal cell carcinoma by downregulating the expression of CDC25B. Cancer Med. 2020;9:1183–95. https://doi.org/10.1002/cam4.2795.

Article  CAS  PubMed  Google Scholar 

Naranjo AI, González-Gómez MJ, Baladrón V, Laborda J, Nueda ML. Different expression levels of DLK2 Inhibit NOTCH signaling and inversely modulate MDA-MB-231 breast cancer tumor growth in vivo. Int J Mol Sci. 2022. https://doi.org/10.3390/ijms23031554.

Article  PubMed  PubMed Central  Google Scholar 

Zhou RJ, Lv HZ. Knockdown of ACTA2-AS1 promotes liver cancer cell proliferation, migration and invasion. Mol Med Rep. 2019;19:2263–70. https://doi.org/10.3892/mmr.2019.9856.

Article  CAS  PubMed  Google Scholar 

Chang JM, Tsai AC, Huang WR, Tseng RC. The alteration of CTNNBIP1 in lung cancer. Int J Mol Sci. 2019. https://doi.org/10.3390/ijms20225684.

Article  PubMed  PubMed Central  Google Scholar 

Wang M, Liu J, Zhao Y, He R, Xu X, Guo X, Li X, Xu S, Miao J, Guo J, Zhang H, Gong J, Zhu F, Tian R, Shi C, Peng F, Feng Y, Yu S, Xie Y, Jiang J, Li M, Wei W, He C, Qin R. Upregulation of METTL14 mediates the elevation of PERP mRNA N(6) adenosine methylation promoting the growth and metastasis of pancreatic cancer. Mol Cancer. 2020;19:130. https://doi.org/10.1186/s12943-020-01249-8.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Huang H, Wang Q, Du T, Lin C, Lai Y, Zhu D, Wu W, Ma X, Bai S, Li Z, Liu L, Li Q. Matrine inhibits the progression of prostate cancer by promoting expression of GADD45B. Prostate. 2018;78:327–35. https://doi.org/10.1002/pros.23469.

Article  CAS  PubMed  Google Scholar 

Wu C, Ying J, Dai M, Peng J, Zhang D. Co-expression of DDR2 and IFITM1 promotes breast cancer cell proliferation, migration and invasion and inhibits apoptosis. J Cancer Res Clin Oncol. 2022;148:3385–98. https://doi.org/10.1007/s00432-022-04110-1.

Article  CAS  PubMed  Google Scholar 

Zhang C, Hua Y, Qiu H, Liu T, Long Q, Liao W, Qiu J, Wang N, Chen M, Shi D, Yan Y, Xie C, Deng W, Li T, Li Y. KMT2A regulates cervical cancer cell growth through targeting VDAC1. Aging (Albany NY). 2020;12:9604–20. https://doi.org/10.18632/aging.103229.

Article  CAS  PubMed  Google Scholar 

Wang J, Li X, Wu H, Wang H, Yao L, Deng Z, Zhou Y. EMP1 regulates cell proliferation, migration, and stemness in gliomas through PI3K-AKT signaling and CD44. J Cell Biochem. 2019;120:17142–50. https://doi.org/10.1002/jcb.28974.

Article  CAS  PubMed  Google Scholar 

Liu W, Zhan Z, Zhang M, Sun B, Shi Q, Luo F, Zhang M, Zhang W, Hou Y, Xiao X, Li Y, Feng H. KAT6A, a novel regulator of β-catenin, promotes tumorigenicity and chemoresistance in ovarian cancer by acetylating COP1. Theranostics. 2021;11:6278–92. https://doi.org/10.7150/thno.57455.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Karamanos NK, Theocharis AD, Piperigkou Z, Manou D, Passi A, Skandalis SS, Vynios DH, Orian-Rousseau V, Ricard-Blum S, Schmelzer CEH, Duca L, Durbeej M, Afratis NA, Troeberg L, Franchi M, Masola V, Onisto M. A guide to the composition and functions of the extracellular matrix. Febs J. 2021;288:6850–912. https://doi.org/10.1111/febs.15776.

Article  CAS  PubMed 

Comments (0)

No login
gif